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Global Cardiovascular Health
Amisha Patel, MDT he World Health Organization, the GlobalAlliance for Chronic Disease, the Institute ofMedicine, and the National Heart, Lung,
and Blood Institute have all emphasized the need
for global health research, particularly in chronic dis-
eases (1–4). However, the need for chronic disease re-
searchers, particularly researchers in cardiovascular
diseases, does not match the workforce capacity at
present (4). Fellowship is a common time to develop
speciﬁc areas of research interest and may provide
an excellent opportunity to initiate global chronic
disease research (5). As a general cardiovascular dis-
ease fellow, I have had the unique opportunity to pur-
sue 10 months of post-doctoral research training in
India, under the funding of the United States Ful-
bright Student Award and the Fogarty Global Health
Fellowship.
Early in my medical training, my interest in health
care advocacy and equitable access to health care
resources made it clear to me that I wanted to incor-
porate a component of international work into my
training and ultimately my career. Other reasons
commonly cited to pursue global health research
include increased immigration to the United States,
the desire of U.S. residents to travel, globalization of
the economy and overseas business interests, more
Americans living abroad, the pursuit of global disease
reduction, the desire for bidirectional information
transfer, intellectual fascination with diseases not
commonly seen in one’s home country, as well as
ethical, humanitarian, and spiritual motivations (5).From the Departments of Preventive Medicine and Medicine-Cardiology,
Northwestern University Feinberg School of Medicine, Chicago, Illinois.
This work was supported in part by the National Institutes of Health/
National Heart, Lung, and Blood Institute through the Fogarty Interna-
tional Clinical Research Scholars and Fellows Program at Vanderbilt
University (R24 TW007988) and the American Recovery and Reinvest-
ment Act.Although my clinical training with plans to pursue
interventional cardiology may seem at odds with my
interest in global health, unique fellowship opportu-
nities have allowed me to meld my interests into a
training program that I hope will set the groundwork
for my career. Here, I present the funding pathways
I pursued, my projects, and the value of overseas
research training to my future pursuits.
The Fulbright U.S. Student Award, a 9-month
award funded by the U.S. Department of State, is
granted in various ﬁelds including the arts, sciences,
and social sciences, with the goal of “increasing
mutual understanding between the United States and
the people of other countries” (6). Eligible applicants
are U.S. citizens who hold a bachelor’s degree, who
are master’s or doctoral candidates, or who are young
professionals. Some academic institutions have a
designated Fulbright Program Adviser who can help
an applicant navigate the application process and
provide insight into areas of interest germane to the
intended purpose of the grant. The application itself
consists of a 2-page statement of grant purpose, an
afﬁliation letter from the institution abroad with
whom the applicant plans to collaborate, a 1-page
personal statement, and 3 reference letters. Depend-
ing on the proposed country of study, there may also
be certain language ﬂuency requirements. Applica-
tions are submitted electronically in the fall prior to
the fellowship, with decisions made in spring of the
following year. If accepted, the grant covers round-
trip airfare to the country of study, a living stipend,
funds for research supplies and excess baggage, a
4-day region-speciﬁc orientation program in Wash-
ington, DC, prior to departure, an in-country orien-
tation upon arrival, and a midyear conference
where grant awardees can present their preliminary
research ﬁndings.
The Fogarty Global Health Program for Fellows and
Scholars is an 11-month award funded by the National
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2145Institutes of Health Fogarty International Center. The
fellowship is geared toward U.S. medical trainees
(doctoral students, post-doctoral fellows, and junior
faculty) who are seeking mentored clinical research
opportunities in low- and middle-income countries
(LMICs). Applicants from LMICs are also eligible to
apply. Five consortia, each composed of 4 U.S. uni-
versities, accept applications and administer the
program. Some consortia accept applications from
external applicants, whereas others do not (Table 1)
(7). I submitted my application through the Vander-
bilt, Emory, Cornell, and Duke (VECD) consortium
because Northwestern University is not included in
any of the consortia. The application itself consists of
a 1,200-word research proposal, essay questions
describing the applicant’s prior research experience,
prior work in resource-limited settings, career goals, a
biographical sketch of both the applicant and the
applicant’s primary mentor, and at least 2 letters of
support. Applications are due on December 1 of each
year, with decisions made in spring of the following
year. If accepted, the grant includes 11 months of
mentored research training support at an LMICTABLE 1 List of 5 Fogarty Global Health Training Consortia, the Insti
Consortium Consortia Institutions Sites
VECD Fogarty
Global Health
Fellowships
Vanderbilt University,
Emory University,
Duke University,
Cornell University
Bangladesh, Brazil, Mexico
Rwanda, Zambia, Vietna
China, Sri Lanka, South
Peru, Haiti, Tanzania,
Kenya, India
Global Health
Equity Scholars
Fellowship
UC Berkeley, Florida
International University,
Stanford University,
Yale University
Ethiopia, Kenya, Uganda,
Zimbabwe, Bangladesh,
India, Malaysia, Russia, U
Brazil, Nicaragua, Peru,
Trinidad & Tobago
GloCal Health
Fellowship
UC San Francisco,
UC San Diego,
UC Los Angeles,
UC Davis
Bangladesh, Brazil, Chile, C
Ethiopia, Guatemala, Ind
Kenya, Mexico, Mozamb
Panama, Peru, Uganda,
Tanzania, Ukraine, Zimb
UJMT Fogarty
Global Health
Fellowship
University of North
Carolina–Chapel Hill,
Johns Hopkins University,
Morehouse School
of Medicine, Tulane
University
Argentina, Bangladesh, Br
China, India, Malaysia, G
Malawi, Peru, South Afr
Swaziland, Tanzania, Th
Uganda, Zambia
Northwestern
Paciﬁc Global
Health Research
Fellows Training
Consortium
University of Washington,
University of Michigan,
University of Minnesota,
University of Hawaii
Kenya, Uganda, Ghana, Pe
Thailand, China, Camero
LMIC ¼ low- and middle-income country; UJMT ¼ University of North Carolina at Chaptraining site and a 1-week orientation and workshop
at the National Institutes of Health Campus in
Bethesda, Maryland.
I was fortunate to receive and to be able to accept
both of these awards, while taking care not to dupli-
cate funding. In my ﬁnal arrangement, I received
most of my research support, including salary, from
Fogarty, whereas the Fulbright Award has provided
travel funds, moving costs, and research supplies.
My research training in India has been an invalu-
able learning experience, because it has encouraged
independence and initiative within a supportive and
collaborative research framework. Under the guid-
ance of the Centre for Chronic Disease Control and
Cardiological Society of India–Kerala Chapter, I am
studying pre-hospital systems of care for patients
with acute coronary syndromes in the south Indian
state of Kerala. My project combines both qualitative
and quantitative research methodologies to study
facilitators of and barriers to optimal pre-hospital
care in this patient population. For the qualitative
portion, I have conducted focus group discussions
and in-depth interviews with a variety of acutetutions Each Includes, and Applicant Eligibility
Are Applicants
External to the
Consortium Eligible?
U.S. Citizens/Permanent Residents LMIC Citizens
Junior
Faculty
Post-
Doctoral
Fellows
Doctoral/Senior
Professional
Students
Junior
Faculty
Post-
Doctoral
Fellows
Doctoral/Senior
Professional
Students
,
m,
Africa,
External
applicants
restricted
X X X
External
applicants
welcome
Not eligible X X
China,
kraine,
External
applicants
restricted
X X X X X X
External
applicants
welcome
hina,
ia,
ique,
abwe
External
applicants
restricted
X X X X Not eligible
External
applicants
welcome
X Not eligible
azil,
hana,
ica,
ailand,
External
applicants
restricted
X X Not eligible
External
applicants
welcome
X X X
ru,
on
External
applicants
restricted
X X X
External
applicants
welcome
Not eligible X X
el Hill, Johns Hopkins, Morehouse, Tulane; VECD ¼ Vanderbilt, Emory, Cornell, Duke.
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gists, emergency department physicians, coronary
care unit nurses, emergency department nurses,
ambulance paramedics, and Kerala’s director of the
Department of Health Services. The quantitative
portion of my proposal collects pre-hospital data as
part of the ACS QUIK (Acute Coronary Syndrome:
Quality Improvement in Kerala) clinical trial that was
launched in Kerala in November 2014 (NCT02256657).
This trial, which includes 63 hospitals throughout
the state, aims to enroll 15,750 patients over the next
2 years. Finally, I am conducting a systematic policy
review of pre-hospital acute coronary syndrome pol-
icies in India by obtaining information from govern-
mental portals, like the National Rural Health Mission
of the Ministry of Health and Family Welfare, and
cardiology professional organizations, like the Cardi-
ological Society of India and the Indian College of
Cardiology.
While in India, I have also had the opportunity to
participate in various other collaborative activities,
including health care advocacy and training work. In
late 2014, I led a group that submitted an application
to add clopidogrel to the World Health Organization’s
Model List of Essential Medicines, a list that guides
national formulary decisions in LMICs and, thus, in-
creases access to and availability of essential medi-
cines. Additionally, my afﬁliation with the Public
Health Foundation of India through the Centre for
Chronic Disease Control has given me the opportunity
to teach classes on health communication and pro-
motion to physicians and nurses from rural commu-
nities in the state of Karnataka, who are enrolled in a
1-year degree course to gain additional training in
public health to apply to their communities. Finally, I
have helped to manage logistics for health care pro-
viders at ACS QUIK–participating hospitals to enrollin and complete online training modules in pa-
tient safety, improvement capability, and family-
centered care from the Institute for Healthcare
Improvement, with the end goal of their earning a
formal certiﬁcation.
My time in India has been an incredibly valuable
experience, not only to enrich my research training
and help set a path where I can marry my interests in
interventional cardiology and global health, but to
also build collaborative relationships that will help
advance care locally. Along the way, I have devel-
oped research skills in qualitative methods that, as a
future interventional cardiologist, I can apply to
process evaluations that assess interventions and
inﬂuence the design of clinical trials. My work in
essential medicines opens the door to potential
future opportunities in health care advocacy and
policy-making. Although the logistics of planning
nearly a year abroad in the midst of a busy clinical
fellowship can be challenging, in my own experience,
the breadth of my research training has been an
incomparable opportunity. Long term, I hope that
these collaborations will extend beyond Kerala and
will encourage the bidirectional transfer of informa-
tion to improve the quality of health care delivery in
the United States as well as in India. For fellows
interested in pursuing a career in global cardiovas-
cular health, the Fulbright and Fogarty grants pro-
vide a structured and mentored funding pathway for
research training.
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2147RESPONSE: Engaging in
Global Cardiovascular Health Research
Rajesh Vedanthan, MD, MPH
Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York
E-mail: rajesh.vedanthan@mssm.eduThe landscape of global cardiovascular health research has
transformed over the past decade, and it continues to
evolve. A decade ago, there were very few funding op-
portunities for investigators interested in global cardio-
vascular health research, and relatively few mentors who
had practical, on-the-ground experience. Over the past
several years, our professional community has seen the
proliferation of funding opportunities targeting trainees
and junior investigators, including the Fogarty Global
Health Program for Fellows and Scholars and the Fulbright
U.S. Student Award, as described by Dr. Patel. In addition,
the Fogarty International Research Scientist Development
Award now includes among its K award recipients several
individuals focusing on global cardiovascular health issues.
The National Heart, Lung, and Blood Institute took a brave
and signiﬁcant step by creating 11 Centers of Excellence
for Cardiovascular and Pulmonary Disease Research in
low- and middle-income countries around the world (1),
and it continues to support productive research enterprises
focusing on global cardiovascular health. The National
Heart, Lung, and Blood Institute is also a founding
member of the Global Alliance for Chronic Diseases, which
has established a network of research teams that span
the globe, addressing hypertension, diabetes, and other
chronic diseases. In addition, there are several nongovern-
mental organizations, such as the Doris Duke Charitable
Foundation, that have also created opportunities for
trainees to engage in meaningful cardiovascular research
projects worldwide. Thus, the opportunities to engage in
global cardiovascular research are much more available
and accessible to trainees and junior investigators.
However, to truly engage requires grit, effort, self-
reﬂection, partnership, and humility. Here, I offer a fewreﬂections on engagement in global cardiovascular health
research. While the funding opportunities are present, Dr.
Patel makes clear that availing of them requires time,
planning, and a lot of hard work. In addition, there are
potential challenges and obstacles, even once funding is
obtained and the project gets initiated. These can span
the gamut from logistical, to cultural, to team dynamics,
and to personal. Thus, time for self-reﬂection is critical
to maintain balance and motivation. If it is difﬁcult, it is
worth it. In the process, our family, friends, collabora-
tors, colleagues, and mentors form a true community to
whom we can turn for guidance, advice, reassurance,
constructive criticism, and partnership. Nearly without
exception, those of us engaged in this ﬁeld recognize
that “we cannot go it alone.” We recognize that the
entire spectrum of activity is important, that each per-
son has a role to play, and that we are, therefore,
interconnected and interdependent in a mutually sup-
portive manner.
Ultimately, this type of engagement will help each of us
learn who we are; what our relationship is to our work, as
well as our relationship to our family and community;
and, most importantly, what our relationship is to the
world. This, of course, is not unique to global cardiovas-
cular health research, but it is the promise of true
engagement in any ﬁeld.
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